초록 ▼

Implantable medical devices, implantable medical device systems that include such implantable medical devices, and implantable medical device batteries, as well as methods of making. Such devices can include a battery of relatively small volume but of relatively high power (reported as therapeutic p

Implantable medical devices, implantable medical device systems that include such implantable medical devices, and implantable medical device batteries, as well as methods of making. Such devices can include a battery of relatively small volume but of relatively high power (reported as therapeutic power) and relatively high capacity (reported as capacity density).

대표청구항 ▼

1. An implantable medical device comprising: control electronics for delivering therapy and/or monitoring physiological signals, the control electronics comprising: a processor; andmemory; andan implantable medical device battery operably connected to the control electronics to deliver power to the

1. An implantable medical device comprising: control electronics for delivering therapy and/or monitoring physiological signals, the control electronics comprising: a processor; andmemory; andan implantable medical device battery operably connected to the control electronics to deliver power to the control electronics; the battery comprising: an anode comprising lithium;a cathode having a total overall thickness of 0.004 inch to 0.014 inch uniform along its length with a tolerance of no more than ±0.003 inch;a separator between the anode and the cathode; andan electrolyte contacting the anode, the cathode, and the separator;wherein the cathode comprises a mixture of active materials comprising a metal oxide;wherein the battery has a therapeutic power of at least 0.11 W for every joule of therapeutic energy delivered over the useful life of the battery, and a therapeutic capacity density of at least 0.08 Ah/cm3. 2. The implantable medical device of claim 1, wherein the cathode comprises a mixture of active materials comprising a metal oxide and carbon monofluoride. 3. An implantable cardioverter defibrillator device comprising: control electronics for delivering therapy and/or monitoring physiological signals, the control electronics comprising: a processor;memory;a stimulation generator that generates at least one of cardiac pacing pulses, defibrillation shocks, and cardioversion shocks; and a sensing module for monitoring a patient's heart rhythm;one or more defibrillator capacitors; andan implantable medical device battery operably connected to the control electronics to deliver power to the control electronics, and operably connected to the capacitors to charge the capacitors; the battery comprising: an anode comprising lithium;a cathode having a total overall thickness of 0.004 inch to 0.014 inch uniform along its length with a tolerance of no more than ±0.003 inch;a separator between the anode and the cathode; andan electrolyte contacting the anode, the cathode, and the separator;wherein the cathode comprises a mixture of active materials comprising a metal oxide;wherein the battery has a therapeutic power of at least 0.11 W for every joule of therapeutic energy delivered over the useful life of the battery, and a therapeutic capacity density of at least 0.08 Ah/cm3. 4. The implantable device of claim 3, wherein the cathode comprises a mixture of active materials comprising a metal oxide and carbon monofluoride. 5. The implantable device of claim 3, wherein the cathode comprises MnO2. 6. The implantable device of claim 5, wherein the battery volume is no greater than 6.0 cm3. 7. The implantable device of claim 3, wherein the therapeutic power of the battery is at least 0.14 W for every joule of therapeutic energy delivered over the useful life of the battery. 8. The implantable device of claim 3, wherein the therapeutic capacity density of the battery is at least 0.10 Ah/cm3. 9. The implantable device of claim 3, wherein the surface area of each of the cathode and anode is at least 60 cm2. 10. The implantable device of claim 3, wherein the cathode comprises a silver vanadium oxide. 11. The implantable device of claim 3, wherein the cathode comprises a single current collector. 12. An implantable medical device comprising: control electronics for delivering therapy and/or monitoring physiological signals, the control electronics comprising: a processor; andmemory; andan implantable medical device battery operably connected to the control electronics to deliver power to the control electronics; the battery comprising: an anode comprising lithium;a cathode comprising a single current collector and having a total overall thickness of 0.004 inch to 0.014 inch uniform along its length with a tolerance of no more than ±0.003 inch;a separator between the anode and the cathode; andan electrolyte contacting the anode, the cathode, and the separator;wherein the cathode further comprises a material comprising a layer on each major surface of the single current collector, wherein the layer comprises a mixture of active materials comprising a metal oxide;wherein the battery has a therapeutic power of at least 0.11 W for every joule of therapeutic energy delivered over the useful life of the battery, and a therapeutic capacity density of at least 0.08 Ah/cm3. 13. The implantable device of claim 12, wherein the cathode layer comprises a mixture of active materials comprising a metal oxide and carbon monofluoride. 14. An implantable medical device system comprising: an implantable medical device of claim 12; andcomponents operably attached to the implantable medical device for delivering therapy and/or monitoring physiological signals. 15. An implantable medical device battery comprising: an anode comprising lithium;a cathode having a total overall thickness uniform along its length with a tolerance of no more than ±0.003 inch; wherein the cathode comprises a mixture of active materials comprising a metal oxide;a separator between the anode and the cathode; andan electrolyte contacting the anode, the cathode, and the separator;wherein the battery has a therapeutic power of at least 0.11 W for every joule of therapeutic energy delivered over the useful life of the battery, and a therapeutic capacity density of at least 0.08 Ah/cm3. 16. The battery of claim 15, wherein the cathode comprises a mixture of active materials comprising a metal oxide and carbon monofluoride. 17. The battery of claim 15, wherein the cathode comprises MnO2. 18. The battery of claim 17, wherein the battery volume no greater than 6.0 cm3. 19. The battery of claim 15, wherein the therapeutic power of the battery is at least 0.14 W for every joule of therapeutic energy delivered over the useful life of the battery. 20. The battery of claim 15, wherein the therapeutic capacity density of the battery is at least 0.10 Ah/cm3. 21. The battery of claim 15, wherein the surface area of each of the cathode and anode is at least 60 cm2. 22. The battery of claim 15, wherein the cathode comprises a silver vanadium oxide. 23. The battery of claim 15, wherein the cathode is prepared from a slurry coated onto a current collector. 24. The battery of claim 15, wherein the cathode material comprises a binder comprising styrene-butadiene-rubber. 25. A method of using an implantable cardioverter defibrillator device, the method comprising: providing an implantable cardioverter defibrillator device comprising: control electronics for delivering therapy and/or monitoring physiological signals, the control electronics comprising: a processor;memory;a stimulation generator that generates at least one of cardiac pacing pulses, defibrillation shocks, and cardioversion shocks; and a sensing module for monitoring a patient's heart rhythm;one or more defibrillator capacitors; andan implantable medical device battery operably connected to the control electronics to deliver power to the control electronics, and operably connected to the capacitors to charge the capacitors;wherein the battery has a therapeutic capacity density of at least 0.08 Ah/cm3; andwherein the battery comprises: an anode comprising lithium;a cathode having a total overall thickness of 0.004 inch to 0.014 inch uniform along its length with a tolerance of no more than ±0.003 inch;a separator between the anode and the cathode; andan electrolyte contacting the anode, the cathode, and the separator;wherein the cathode comprises a mixture of active materials comprising a metal oxide;activating the battery to provide a therapeutic power of at least 0.11 W for every joule of therapeutic energy delivered over the useful life of the battery. 26. The method of claim 25, wherein the cathode comprises MnO2. 27. The method of claim 26, wherein the battery volume is no greater than 6.0 cm3. 28. The method of claim 25, wherein the therapeutic power of the battery is at least 0.14 W for every joule of therapeutic energy delivered over the useful life of the battery. 29. The method of claim 25, wherein the therapeutic capacity density of the battery is at least 0.10 Ah/cm3. 30. The method of claim 25, wherein the surface area of each of the cathode and anode is at least 60 cm2. 31. The method of claim 25, wherein the cathode comprises a silver vanadium oxide.